Tricyclic urea compounds as JAK2 V617F inhibitors
US11780840B2 · kind B2 · utility
3Cited by
19References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2021 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.